Reference
Prodosmo A, et al. Detection of ATM germline variants by the p53 mitotic centrosomal localization test in BRCA1/2-negative patients with early-onset breast cancer. J Exp Clin Cancer Res. 2016;35:135. doi:10.1186/s13046-016-0410-3.
Author information
Authors and Affiliations
Corresponding authors
Additional information
The online version of the original article can be found under doi:10.1186/s13046-016-0410-3.
The online version of the original article can be found at http://dx.doi.org/10.1186/s13046-016-0410-3.
Additional file
Additional file 1:
Characteristics of ATM variants. (DOCX 16 kb)
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Prodosmo, A., Buffone, A., Mattioni, M. et al. Erratum to: Detection of ATM germline variants by the p53 mitotic centrosomal localization test in BRCA1/2-negative patients with early-onset breast cancer. J Exp Clin Cancer Res 35, 185 (2016). https://doi.org/10.1186/s13046-016-0459-z
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s13046-016-0459-z